Bristol-Myers Squibb Company
BMS
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Lobbying Activity
Meeting with Andi Cristea (Member of the European Parliament) and
25 Nov 2025 · Recent developments in EU-US trade policy
Meeting with Michele Picaro (Member of the European Parliament)
20 Nov 2025 · Meeting
Meeting with Hildegard Bentele (Member of the European Parliament) and
8 Oct 2025 · Biotech
Meeting with Victor Negrescu (Member of the European Parliament) and
8 Oct 2025 · AmCham EU Healthcare Committee Meeting
Meeting with Giulia Del Brenna (Head of Unit Internal Market, Industry, Entrepreneurship and SMEs)
30 Sept 2025 · Issues and concerns related to the EU’s competitiveness in this sector, in particular regarding European legislation, U.S. tariffs on pharmaceuticals, and intellectual property.
Meeting with Rainer Becker (Director Health and Food Safety)
17 Sept 2025 · Exchange on clinical trials in the context of the upcoming proposal for an EU Biotech Act
Meeting with Aurelijus Veryga (Member of the European Parliament)
10 Sept 2025 · The Critical Medicines Act: Opportunities Ahead
Meeting with Sirpa Pietikäinen (Member of the European Parliament)
10 Sept 2025 · Critical Medicines Act and procurement
Meeting with Oliver Schenk (Member of the European Parliament, Rapporteur for opinion)
30 Jul 2025 · Critical Medicines Act
Meeting with Viktória Ferenc (Member of the European Parliament)
2 Jul 2025 · Introduction, exchange of views on pharmaceutical legislation
Meeting with Kris Van Dijck (Member of the European Parliament)
30 Apr 2025 · pharma industry in the EU
Meeting with Andreas Glück (Member of the European Parliament)
22 Jan 2025 · Health
Meeting with Tomislav Sokol (Member of the European Parliament)
22 Jan 2025 · Health Policy
Meeting with Aurelijus Veryga (Member of the European Parliament)
21 Jan 2025 · The Future of Clinical Trials and the EU Life Sciences Strategy
Meeting with Elena Nevado Del Campo (Member of the European Parliament)
21 Jan 2025 · Biotech sector in the EU
Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament)
13 Sept 2024 · Introductory Meeting
Meeting with András Tivadar Kulja (Member of the European Parliament)
11 Sept 2024 · European Health policy
Meeting with Christian Ehler (Member of the European Parliament)
19 Jul 2024 · European industrial policy
Meeting with Deirdre Clune (Member of the European Parliament)
21 Feb 2024 · Pharmaceutical Package
Meeting with Ondřej Knotek (Member of the European Parliament)
20 Feb 2024 · Pharmaceutical package
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Affordable Medicines Europe
5 Jan 2024 · Directive on Medicinal products for human use
Meeting with Javier Zarzalejos (Member of the European Parliament, Shadow rapporteur)
4 Dec 2023 · Meeting with Bristol Myers Squibb to discuss the Supplementary protection certificates (SPCs) package
Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and Novo Nordisk A/S
15 Nov 2023 · Pharmaceutical legislation
Meeting with Catherine Amalric (Member of the European Parliament, Shadow rapporteur)
8 Nov 2023 · Reform of the EU pharmaceutical legislation
Meeting with Javier Zarzalejos (Member of the European Parliament, Shadow rapporteur)
6 Nov 2023 · Meeting with Bristol Myers Squibb to discuss the Supplementary protection certificates (SPCs) package
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)
10 Oct 2023 · Directive on Medicinal products for human use
Meeting with Tom Vandenkendelaere (Member of the European Parliament)
5 Oct 2023 · pharmaceutical review
Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)
4 Oct 2023 · SPC Package (staff level)
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and
11 Jul 2023 · Directive on Medicinal products for human use
Meeting with Billy Kelleher (Member of the European Parliament)
28 Jun 2023 · Pharmaceutical Strategy
Meeting with Stelios Kympouropoulos (Member of the European Parliament)
7 Apr 2023 · National Action Plan for Cancer and EU opportunities
Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur)
15 Nov 2022 · European Health Data Space - EHDS
Meeting with Tom Vandenkendelaere (Member of the European Parliament)
19 Apr 2022 · General introduction
Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC
26 Apr 2021
Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products
6 Jan 2021
Response to Commission Communication on Europe’s Beating Cancer Action Plan
3 Mar 2020
Meeting with Juho Romakkaniemi (Cabinet of Vice-President Jyrki Katainen)
8 Dec 2016 · Innovation and investment
Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)
8 Dec 2016 · HTA, HSPA